These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10550839)

  • 1. Molecular modalities in the treatment of lung cancer.
    Carbone DP
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):142-7. PubMed ID: 10550839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
    Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for lung cancer: practice and promise.
    Vattemi E; Claudio PP
    Ann Ital Chir; 2004; 75(3):279-89. PubMed ID: 15605515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel molecular and immunotherapeutic strategies for lung cancer.
    Pass HI; Kalemkerian G; Bright RK
    Chest Surg Clin N Am; 2001 Feb; 11(1):189-212, ix. PubMed ID: 11253598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
    Zhang WW; Roth JA
    In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Yang SC; Batra RK; Hillinger S; Reckamp KL; Strieter RM; Dubinett SM; Sharma S
    Cancer Res; 2006 Mar; 66(6):3205-13. PubMed ID: 16540672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
    Chen J; Cao X; Xiu Q
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy of lung cancer.
    Daniel JC; Smythe WR
    Semin Surg Oncol; 2003; 21(3):196-204. PubMed ID: 14508853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
    Sharma S; Stolina M; Zhu L; Lin Y; Batra R; Huang M; Strieter R; Dubinett SM
    Cancer Res; 2001 Sep; 61(17):6406-12. PubMed ID: 11522634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer?
    Raben D; Helfrich B
    Clin Lung Cancer; 2004 Jul; 6(1):48-57. PubMed ID: 15310417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and lung cancer.
    Brambilla E; Brambilla C
    Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.
    Yamaguchi Y; Ohta K; Kawabuchi Y; Ohshita A; Okita R; Okawaki M; Hironaka K; Matsuura K; Toge T
    Anticancer Res; 2005; 25(3c):2407-15. PubMed ID: 16080467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.
    Kozin SV; Boucher Y; Hicklin DJ; Bohlen P; Jain RK; Suit HD
    Cancer Res; 2001 Jan; 61(1):39-44. PubMed ID: 11196192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for lung cancer.
    Haura EB; Sotomayor E; Antonia SJ
    Mol Biotechnol; 2003 Oct; 25(2):139-48. PubMed ID: 14526124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant adenovirus expressing wild-type p53 is antiagiogenic--implication for lung cancer gene therapy].
    Fujiwara T; Nishizaki M; Tanaka N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1217-24. PubMed ID: 10945020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
    Kakimi K; Nakajima J; Wada H
    Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 tumor suppressor gene therapy for cancer.
    Roth JA; Swisher SG; Meyn RE
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
    Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.